Alsaggaf R, Pfeiffer R, Pearce E, Greene M, Lochmuller H, Gadalla S
Muscle Nerve. 2024; 71(2):229-236.
PMID: 39679826
PMC: 11708454.
DOI: 10.1002/mus.28308.
Shear M, Penon-Portmann M, Shieh J, Glenn O, Thiet M, Chetty S
Neurol Genet. 2024; 10(6):e200171.
PMID: 39444647
PMC: 11498903.
DOI: 10.1212/NXG.0000000000200171.
Ronnblom A, Ekbom A
Ups J Med Sci. 2024; 129.
PMID: 39376588
PMC: 11457906.
DOI: 10.48101/ujms.v129.10663.
Wu Y, Wei Q, Lin J, Shang H, Ou R
Front Cell Neurosci. 2024; 18:1369332.
PMID: 38638300
PMC: 11024338.
DOI: 10.3389/fncel.2024.1369332.
Jia Y, Dong C, Xue J, Duan X, Xu M, Su X
World J Clin Cases. 2022; 10(20):7060-7067.
PMID: 36051128
PMC: 9297391.
DOI: 10.12998/wjcc.v10.i20.7060.
12-Month progression of motor and functional outcomes in congenital myotonic dystrophy.
Quigg K, Berggren K, McIntyre M, Bates K, Salmin F, Casiraghi J
Muscle Nerve. 2020; 63(3):384-391.
PMID: 33341951
PMC: 8038871.
DOI: 10.1002/mus.27147.
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?.
Dhont S, Callens R, Stevens D, Bauters F, De Bleecker J, Derom E
Acta Neurol Belg. 2020; 121(6):1761-1765.
PMID: 33052531
PMC: 7556549.
DOI: 10.1007/s13760-020-01514-z.
Two Adult Siblings With Myotonic Dystrophy Type 1 With Different Phenotypes Presenting With Chronic Respiratory Insufficiency and Sleep Apnea Syndrome.
Kohno G, Ogawa K, Kushimoto M, Tanaka S, Ikeda J, Nishizawa T
Front Neurol. 2019; 10:681.
PMID: 31333559
PMC: 6620565.
DOI: 10.3389/fneur.2019.00681.
Core Clinical Phenotypes in Myotonic Dystrophies.
Wenninger S, Montagnese F, Schoser B
Front Neurol. 2018; 9:303.
PMID: 29770119
PMC: 5941986.
DOI: 10.3389/fneur.2018.00303.
Myotonic Dystrophy and Developmental Regulation of RNA Processing.
Thomas J, Oliveira R, Sznajder L, Swanson M
Compr Physiol. 2018; 8(2):509-553.
PMID: 29687899
PMC: 11323716.
DOI: 10.1002/cphy.c170002.
Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
Hamilton M, Robb Y, Cumming S, Gregory H, Duncan A, Rahman M
PLoS One. 2017; 12(3):e0174166.
PMID: 28323905
PMC: 5360313.
DOI: 10.1371/journal.pone.0174166.
Physical function and mobility in children with congenital myotonic dystrophy.
Pucillo E, Dibella D, Hung M, Bounsanga J, Crockett B, Dixon M
Muscle Nerve. 2016; 56(2):224-229.
PMID: 27859360
PMC: 5436951.
DOI: 10.1002/mus.25482.
Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
Gao Y, Guo X, Santostefano K, Wang Y, Reid T, Zeng D
Mol Ther. 2016; 24(8):1378-87.
PMID: 27203440
PMC: 5023370.
DOI: 10.1038/mt.2016.97.
Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.
Mutchnick I, Thatikunta M, Gump W, Stewart D, Moriarty T
Childs Nerv Syst. 2016; 32(4):609-16.
PMID: 26747623
DOI: 10.1007/s00381-015-2993-y.
Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.
Ho G, Cardamone M, Farrar M
World J Clin Pediatr. 2015; 4(4):66-80.
PMID: 26566479
PMC: 4637811.
DOI: 10.5409/wjcp.v4.i4.66.
The Change of Grip Strength in a Patient with Congenital Myotonic Dystrophy Over a 4-year Period.
Kikuchi S, Kozuka N, Uchida E, Ninomiya T, Tatsumi H, Takeda H
J Jpn Phys Ther Assoc. 2015; 11(1):23-7.
PMID: 25792886
PMC: 4316524.
DOI: 10.1298/jjpta.11.23.
Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.
Bouchard J, Cossette L, Bassez G, Puymirat J
J Neurol. 2014; 262(2):285-93.
PMID: 25380585
DOI: 10.1007/s00415-014-7570-x.
Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.
Kumar A, Agarwal S, Pradhan S
Case Rep Med. 2014; 2014:289643.
PMID: 24715907
PMC: 3970441.
DOI: 10.1155/2014/289643.
Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.
Todd P, Ackall F, Hur J, Sharma K, Paulson H, Dowling J
Dis Model Mech. 2013; 7(1):143-55.
PMID: 24092878
PMC: 3882056.
DOI: 10.1242/dmm.012427.
Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol. 2013; 45(10):2280-7.
PMID: 23796888
PMC: 3759660.
DOI: 10.1016/j.biocel.2013.06.010.